0000000000362334

AUTHOR

Florence Bichat

showing 9 related works from this author

Prevalence, risk factor burden, and severity of coronary artery disease in patients with heterozygous familial hypercholesterolemia hospitalized for …

2019

Individuals with heterozygous familial hypercholesterolemia (FH) are at high risk of early myocardial infarction (MI). However, coronary artery disease (CAD) burden of FH remains not well described, especially for French patients.The objective of this study was to assess the prevalence of FH and severity of CAD from a large database of a French regional registry of acute MI.All consecutive patients hospitalized for an acute MI in a multicenter database from 2001 to 2017 were considered. FH was diagnosed using an algorithm adapted from the Dutch Lipid Clinic Network criteria. The prevalence and clinical features of FH and the severity of CAD were assessed.Among the 11,624 patients included i…

Heterozygotemedicine.medical_specialtyEndocrinology Diabetes and Metabolism[SDV]Life Sciences [q-bio]Myocardial InfarctionFamilial hypercholesterolemia030204 cardiovascular system & hematologySeverity of Illness IndexCohort StudiesHyperlipoproteinemia Type IICoronary artery disease03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinePrevalenceInternal MedicinemedicineHumansIn patientRegistries030212 general & internal medicineMyocardial infarctionRisk factorAcute miLipid clinicAgedAged 80 and overNutrition and Dieteticsbusiness.industryCholesterol LDLMiddle AgedEzetimibemedicine.disease3. Good healthLarge cohortHospitalizationFranceHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular Medicinebusiness
researchProduct

P4550Growth differentiation factor 15 as an integrative biomarker of heart failure in patients with acute myocardial infarction

2019

Abstract Background Growth differentiation factor 15 (GDF15), a stress-responsive cytokine member of the transforming growth factor-β family, is an emerging biomarker in cardiovascular (CV) diseases. GDF15 is weakly expressed in normal condition but increased in pathological situations such as inflammation, oxidative stress, and left ventricular remodeling. Recent data suggest GDF15 as a marker in heart failure (HF). Purpose We aimed to identify the determinants of GDF15 circulating levels in patients admitted for an acute myocardial infarction (AMI). Methods In our prospective study, all consecutive patients admitted from June 2016 to February 2018 for type 1 AMI in the Coronary Care unit …

medicine.medical_specialtybusiness.industryInternal medicineHeart failuremedicineCardiologyBiomarker (medicine)In patientMyocardial infarctionCardiology and Cardiovascular Medicinebusinessmedicine.diseaseEuropean Heart Journal
researchProduct

Association between Serum Osteoprotegerin Levels and Severity of Coronary Artery Disease in Patients with Acute Myocardial Infarction

2021

International audience; Background. Osteoprotegerin (OPG), a glycoprotein of the tumour necrosis factor (TNF) superfamily, is one of the main biomarkers for vascular calcification. Aim. We aimed to evaluate the association between serum OPG levels and extent of coronary lesions in patients with acute myocardial infarction (MI). Methods. Consecutive patients hospitalized for an acute MI who underwent coronary angiography were included. SYNTAX score was calculated to assess the severity of coronary artery disease. The population was analysed in low (5 (3–6)), medium (11 (9–13)) and high (20 (18–23)) tertiles of SYNTAX score. Results. Among the 378 patients included, there was a gradual increa…

musculoskeletal diseasesmedicine.medical_specialtyNecrosisPopulationRenal function030204 cardiovascular system & hematologyCoronary artery disease03 medical and health sciences0302 clinical medicineOsteoprotegerin[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemDiabetes mellitusInternal medicinemedicineMyocardial infarction030212 general & internal medicineeducation030304 developmental biology0303 health scienceseducation.field_of_studyEjection fractionbusiness.industryBrief ReportRGeneral Medicinemedicine.diseaseSYNTAX scoremyocardial infarctionosteoprotegerinvascular calcificationCardiologyMedicinemedicine.symptombusinessCardiology and Cardiovascular Medicinecoronary artery diseaseJournal of Clinical Medicine
researchProduct

Sport-related acute myocardial infarction; Context of onset and one-year follow-up

2021

Background Sport-related (SR) acute coronary events are the main cause of sudden cardiac in the setting of sport activities; data are very scarce regarding the context of onset and the follow-up of SR acute myocardial infarction (AMI). Methods We prospectively invited subjects admitted in our University Hospital from April 2018 for a SR-AMI to participate in the IMACS observatory program which addresses to SR-AMI including a 12 months follow-up. Results From April 2018 to April 2019, 21 subjects were included. The mean age of this male population was 57.5 ± 11.0 (median 56). The context of event was available for 21 (provided by family for a subject with out of hospital (OH) SCA). Sport was…

Pediatricsmedicine.medical_specialtyRehabilitationOne year follow upbiologybusiness.industrymedicine.medical_treatmentContext (language use)medicine.diseasebiology.organism_classificationUniversity hospitalMedical advicemedicineMyocardial infarctionCardiopulmonary resuscitationCannabisCardiology and Cardiovascular MedicinebusinessArchives of Cardiovascular Diseases Supplements
researchProduct

Alarming increased rate of smoking and associated lifestyle behaviours in patients with chronic cardiac diseases during COVID-19 pandemic related loc…

2021

Background COVID-19 outbreak and lockdown is a situation associating social and physical isolation, limited care access, psychological stress, and potential adoption of unhealthy lifestyle behaviours such as smoking. In a cohort of outpatients with chronic cardiac diseases, including congestive heart failure (CHF) and chronic coronary syndromes (CCS), we aimed to evaluate the impact of Covid-19 outbreak on tobacco consumption. Patients and methods During the 6th week of lockdown (which had started on March, 17th), 150 randomly selected CHF patients (from the Dijon HF-Clinic) and 250 CCS patients from the RICO survey were invited to answer an anonymous questionnaire. The 20-min lasting phone…

medicine.medical_specialtyIsolation (health care)Coronavirus disease 2019 (COVID-19)business.industryOutbreakDisease030204 cardiovascular system & hematologymedicine.diseaseNicotine03 medical and health sciences0302 clinical medicine417Heart failureEmergency medicinePandemicCohortmedicine030212 general & internal medicineCardiology and Cardiovascular Medicinebusinessmedicine.drugArchives of Cardiovascular Diseases Supplements
researchProduct

2214Prevalence and severity of coronary disease in patients with familial hypercholesterolemia hospitalized for an acute myocardial infarction: data …

2019

Abstract Aim Individuals with heterozygous familial hypercholesterolemia (FH) are at high risk of early myocardial infarction (MI). However, coronary artery disease (CAD) burden of FH remains not well described. From a large database of a regional registry of acute MI, we aimed to address prevalence of FH and severity of CAD. Methods Consecutive patients hospitalized with MI in a multicentre database from 2001–2017 were considered. An algorithm, adapted from Dutch Lipid Clinic Network criteria, was built upon 4 variables (LDL-cholesterol (LDL-C) and lipid lowering agents, premature and family history of CAD) to identify FH probabilities. Results Among the 11624 patients included in the surv…

medicine.medical_specialtybusiness.industryCoronary arteriosclerosisFamilial hypercholesterolemiaCoronary diseasemedicine.diseaseEzetimibeInternal medicineDiabetes mellitusEpidemiologymedicineIn patientMyocardial infarctionCardiology and Cardiovascular Medicinebusinessmedicine.drugEuropean Heart Journal
researchProduct

Impact pronostique de l’HbA1c et de la glycémie plasmatique (Gp) à la phase aiguë d’un infarctus du myocarde sur la mortalité à un an chez des patien…

2020

International audience; Background: The usefulness of the combined assessment of HbA1c and plasma glucose (PG) in acute myocardial infarction (AMI) in non-diabetic patients remains unclear.Purpose: In a large observational study, we aimed to identify the prognostic values of these biomarkers regarding one-year all-cause mortality in non-diabetic patients after AMI.Methods: From the "obseRvatoire des Infarctus de Côte d'Or" (RICO) survey database, we included all consecutive non-diabetic patients with AMI (n=6617) from May 2001 to December 2016. Exclusion criteria were: admission known or unknown diabetes, in-hospital death. The primary endpoint was all-cause one-year mortality. The secondar…

Gynecologymedicine.medical_specialtyHbA1cbusiness.industryGlycemic stress[SDV]Life Sciences [q-bio]Non-diabetic030204 cardiovascular system & hematologyMyocardial infraction3. Good health[SDV] Life Sciences [q-bio]One year mortality03 medical and health sciencesOne-year mortality0302 clinical medicineMedicineCardiology and Cardiovascular MedicinebusinessNon diabetic
researchProduct

High Levels of Asymmetric Dimethylarginine Are Strongly Associated with Low HDL in Patients with Acute Myocardial Infarction

2013

International audience; Objectives: Low levels of high-density lipoprotein (HDL) cholesterol are associated with an increased risk of acute myocardial infarction possibly through impaired endothelial atheroprotection and decreased nitric oxide (NO) bioavailability. Asymmetric dimethylarginine (ADMA) mediates endothelial function by inhibiting nitric oxide synthase activity. In patients with acute myocardial infarction, we investigated the relationship between serum levels of HDL and ADMA. Approach and Results: Blood samples from 612 consecutive patients hospitalized for acute MI ,24 hours after symptom onset were taken on admission. Serum levels of ADMA, its stereoisomer, symmetric dimethyl…

MaleArginineEpidemiologyMyocardial Infarctionlcsh:Medicine030204 cardiovascular system & hematologyCardiovascularBiochemistrychemistry.chemical_compound0302 clinical medicineMedicineMyocardial infarctionlcsh:ScienceChromatography High Pressure Liquid0303 health sciencesMultidisciplinarybiologyNeurochemistryMiddle Aged[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system3. Good healthNitric oxide synthaseBlood ChemistryMedicinelipids (amino acids peptides and proteins)FemaleNeurochemicalsLipoproteins HDLResearch Articlemedicine.medical_specialtyClinical Research DesignLipoproteinsNitric OxideArginineNitric oxide03 medical and health sciences[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemInternal medicineHumansBiologyCardiovascular Disease Epidemiology030304 developmental biologyAgedPopulation Biologybusiness.industryCholesterollcsh:RProteinsmedicine.diseaseBioavailabilityBiomarker EpidemiologyEndocrinologychemistrybiology.proteinlcsh:QbusinessAsymmetric dimethylarginineLipoproteinNeurosciencePLoS ONE
researchProduct

003 Pericardial effusion in acute myocardial infarction: new insights from the French regional RICO survey

2012

medicine.medical_specialtybusiness.industrymedicineMyocardial infarctionIntensive care medicinemedicine.diseasebusinessCardiology and Cardiovascular MedicinePericardial effusionArchives of Cardiovascular Diseases Supplements
researchProduct